171 related articles for article (PubMed ID: 24708238)
1. Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats.
Mosti MP; Stunes AK; Ericsson M; Pullisaar H; Reseland JE; Shabestari M; Eriksen EF; Syversen U
Endocrinology; 2014 Jun; 155(6):2178-89. PubMed ID: 24708238
[TBL] [Abstract][Full Text] [Related]
2. The PPARα Agonist Fenofibrate Improves the Musculoskeletal Effects of Exercise in Ovariectomized Rats.
Mosti MP; Ericsson M; Erben RG; Schüler C; Syversen U; Stunes AK
Endocrinology; 2016 Oct; 157(10):3924-3934. PubMed ID: 27526032
[TBL] [Abstract][Full Text] [Related]
3. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
5. Skeletal effects of plyometric exercise and metformin in ovariectomized rats.
Stunes AK; Erben RG; Schüler C; Eriksen EF; Tice M; Vashishth D; Syversen U; Mosti MP
Bone; 2020 Mar; 132():115193. PubMed ID: 31857252
[TBL] [Abstract][Full Text] [Related]
6. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
[TBL] [Abstract][Full Text] [Related]
7. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI
Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo.
Still K; Grabowski P; Mackie I; Perry M; Bishop N
Calcif Tissue Int; 2008 Oct; 83(4):285-92. PubMed ID: 18836674
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
11. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
12. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
13. Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats.
Bonnet N; Laroche N; Vico L; Dolleans E; Benhamou CL; Courteix D
J Pharmacol Exp Ther; 2006 Sep; 318(3):1118-27. PubMed ID: 16740619
[TBL] [Abstract][Full Text] [Related]
14. Differences in bone turnover and skeletal response to thyroid hormone treatment between estrogen-depleted and repleted rats.
Zeni S; Gomez-Acotto C; Di Gregorio S; Mautalen C
Calcif Tissue Int; 2000 Aug; 67(2):173-7. PubMed ID: 10920223
[TBL] [Abstract][Full Text] [Related]
15. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
16. The effects of PPARδ agonist and zinc on ovariectomized rats' vagina.
Takacs P; Jaramillo S; Zhang Y; Datar R; Williams A; Olczyk J; Candiotti K; Medina CA
Female Pelvic Med Reconstr Surg; 2013; 19(3):126-31. PubMed ID: 23611928
[TBL] [Abstract][Full Text] [Related]
17. Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats.
Smith SY; Samadfam R; Chouinard L; Awori M; Bénardeau A; Bauss F; Guldberg RE; Sebokova E; Wright MB
J Bone Miner Metab; 2015 Nov; 33(6):625-41. PubMed ID: 25534548
[TBL] [Abstract][Full Text] [Related]
18. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.
Sprecher DL; Massien C; Pearce G; Billin AN; Perlstein I; Willson TM; Hassall DG; Ancellin N; Patterson SD; Lobe DC; Johnson TG
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):359-65. PubMed ID: 17110604
[TBL] [Abstract][Full Text] [Related]
19. Effects of a beta 3 adrenergic receptor agonist on bone and bone marrow adipocytes in the tibia and lumbar spine of the ovariectomized rat.
Kurabayashi T; Tomita M; Matsushita H; Honda A; Takakuwa K; Tanaka K
Calcif Tissue Int; 2001 Apr; 68(4):248-54. PubMed ID: 11353953
[TBL] [Abstract][Full Text] [Related]
20. The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats.
Devareddy L; Khalil DA; Korlagunta K; Hooshmand S; Bellmer DD; Arjmandi BH
Menopause; 2006; 13(4):692-9. PubMed ID: 16837891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
